Analysis Pharmacovigilance

Medicare ACO savings data: what a PV team can and cannot take from CMS's 2025 results

CMS reports $2.5bn net savings and 12.6m beneficiaries in the Shared Savings Program. The records contain no drug-safety content, so the relevance to pharmacovigilance is indirect.

VigiEye editorial · Wed 18 Nov 2026

What CMS published

On 17 November CMS issued a fact sheet on the financial and quality results of Medicare Shared Savings Program (MSSP) accountable care organisations (ACOs) for Performance Year 2025. The records available to us do not include the fact sheet's figures. We cannot report quality scores or per-ACO results.

A companion CMS press release gives the headline numbers. ACOs in the programme reached a record 12.6 million beneficiaries, and net savings to Medicare topped $2.5 billion. CMS describes this as the ninth straight year of savings.

In general terms, the MSSP lets groups of providers take shared responsibility for the cost and quality of care for a defined population of Medicare beneficiaries. They can share in savings if they meet quality requirements. Nothing in the records links these results to medicines, adverse events or safety reporting.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Sources this analysis is based on

Written by VigiEye's editorial system with AI assistance (model claude-sonnet-5-5) strictly from the official records listed above. It can contain errors: check the sources before acting. Not legal, medical or investment advice.

More analysis & opinionAll →